MoneyWorks4Me

Indoco Remedies informs about newspaper publication

18 Oct 2025 Evaluate
Indoco Remedies has informed that the Investor Education and Protection Fund Authority (IEPFA), Ministry of Corporate Affairs, has initiated a 100 days Campaign - ‘Saksham Niveshak’, to create awareness among shareholders and facilitate settlement of unpaid/unclaimed dividends. In view of the above, it has enclosed the initiatives undertaken by the Company for the aforementioned Campaign: 1. Copy of Communication issued to the shareholder under the title:- 100 days Campaign - ‘Saksham Niveshak’, to reach out to shareholders whose dividend remains unpaid/ unclaimed; 2. Copy of notice published in ‘Business Standard’ (All India Edition) (English Newspaper) and Mumbai Lakshadeep (Marathi Newspaper) on 18th October, 2025

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

221.60 -0.25 (-0.11%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: